Alliance provides one-stop biosafety testing service

Beckman Coulter Genomics and Vitrology Ltd have announced a strategic partnership to offer customers a wide range of biosafety testing services. The alliance provides the biopharmaceutical industry with two inclusive sources for the full complement of molecular, in vitro and in vivo genomic services necessary for the identification, stabilisation and purification of biological products.

The alliance also provides customers with access to the next-generation sequencing technologies that are revolutionising biology. It is widely recognised that massively parallel sequencing technologies hold incredible promise for the study of DNA sequence variation in vaccines, cell banks and gene therapy products, and allow the use of an open-question approach for the safety characterisation of biologics.

Beckman Coulter Genomics provides Sanger and next-generation DNA sequencing, gene expression profiling, genotyping and biologics testing services. The collaboration between Beckman Coulter Genomics and Vitrology further expands and complements both companies’ extensive biologics testing services portfolios, which are available to clients worldwide.